Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Kreishman-Deitrick

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Tropical Medicine and Hygiene|June 6, 2014
In responseMax Grogl, Nestor Sosa, Mara Kreishman-Deitrick
Nature Cell Biology|February 9, 2002
Ignition of a cellular machineMara Kreishman-Deitrick, Michael K Rosen, Mara Kreishman-Deltrick
Military Medicine|February 20, 2020
Army Antimalarial Drug Development: An Advanced Development Case Study for TafenoquineVictor E Zottig, Katherine A Carr, John G Clarke, et al.
Biochemistry|July 16, 2003
NMR analysis of methyl groups at 100-500 kDa: model systems and Arp2/3 complexMara Kreishman-Deitrick, Coumaran Egile, David W Hoyt, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli beta-ketoacyl-ACP-synthase III (FabH)Mamoun M Alhamadsheh, Norman C Waters, Donald P Huddler, et al.
Journal of Medicinal Chemistry|February 6, 2015
Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivativesVasiliy Korotchenko, Ramadas Sathunuru, Lucia Gerena, et al.
Biochemistry|November 16, 2005
NMR analyses of the activation of the Arp2/3 complex by neuronal Wiskott-Aldrich syndrome proteinMara Kreishman-Deitrick, Erin D Goley, Lyle Burdine, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 20, 2019
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasisDiana Caridha, Brian Vesely, Katrien van Bocxlaer, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2013
Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasisWilliam R Ravis, Alejandro Llanos-Cuentas, Nestor Sosa, et al.
The American Journal of Tropical Medicine and Hygiene|July 17, 2013
Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in PanamaNéstor Sosa, Zeuz Capitán, Javier Nieto, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Tropical Medicine and Hygiene|June 6, 2014
In responseMax Grogl, Nestor Sosa, Mara Kreishman-Deitrick
Nature Cell Biology|February 9, 2002
Ignition of a cellular machineMara Kreishman-Deitrick, Michael K Rosen, Mara Kreishman-Deltrick
Military Medicine|February 20, 2020
Army Antimalarial Drug Development: An Advanced Development Case Study for TafenoquineVictor E Zottig, Katherine A Carr, John G Clarke, et al.
Biochemistry|July 16, 2003
NMR analysis of methyl groups at 100-500 kDa: model systems and Arp2/3 complexMara Kreishman-Deitrick, Coumaran Egile, David W Hoyt, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli beta-ketoacyl-ACP-synthase III (FabH)Mamoun M Alhamadsheh, Norman C Waters, Donald P Huddler, et al.
Journal of Medicinal Chemistry|February 6, 2015
Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivativesVasiliy Korotchenko, Ramadas Sathunuru, Lucia Gerena, et al.
Biochemistry|November 16, 2005
NMR analyses of the activation of the Arp2/3 complex by neuronal Wiskott-Aldrich syndrome proteinMara Kreishman-Deitrick, Erin D Goley, Lyle Burdine, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 20, 2019
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasisDiana Caridha, Brian Vesely, Katrien van Bocxlaer, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2013
Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasisWilliam R Ravis, Alejandro Llanos-Cuentas, Nestor Sosa, et al.
The American Journal of Tropical Medicine and Hygiene|July 17, 2013
Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in PanamaNéstor Sosa, Zeuz Capitán, Javier Nieto, et al.
Pageof 3